SuperworthMoleculin Biotech shares outstanding MBRX
Diluted shares outstanding, averaged over each quarter, from 2016.
- Latest quarter, to Dec 31, 2021
- 3.8K
- On a year earlier
- +162.5%
- more shares
Moleculin Biotech had 3.8K diluted shares outstanding on average in Q4 FY21, the quarter to Dec 31, 2021.
That is 162.5% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2021 | 3.8K | +163% |
| FY2020 | 1.5K | +43% |
| FY2019 | 1K | +66% |
| FY2018 | 611 | +30% |
| FY2017 | 471 | +75% |
| FY2016 | 269 | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q4 FY21 | 3.8K | +163% | |
| Q3 FY21 | 3.8K | +179% | |
| Q2 FY21 | 3.8K | +187% | |
| Q1 FY21 | 2.9K | +162% | |
| Q4 FY20 | 1.5K | +43% | |
| Q3 FY20 | 1.4K | +35% | |
| Q2 FY20 | 1.3K | +40% | |
| Q1 FY20 | 1.1K | +72% | |
| Q4 FY19 | 1K | +66% | |
| Q3 FY19 | 1K | +69% | |
| Q2 FY19 | 942 | +64% | |
| Q1 FY19 | 646 | +25% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Moleculin Biotech
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.